Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages
✍ Scribed by Jean-Marc Cavaillon; Catherine Fitting; Nicole Haeffner-Cavaillon
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 417 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Monocyte/macrophage polypeptides (monokines) alter the properties of synovial cells. This interaction could explain some of the properties of the inflamed synovium in rheumatic disease. Only recently has it been possible to test the action of purified monokines on the target synovial cells. We repor
## Abstract The outcome of total joint arthroplasty is determined by biological events at the bone‐implant interface. Macrophages phagocytose implant or wear debris at the interface and release proinflammatory mediators such as interleukins 1 and 6, tumor necrosis factor‐alpha, and prostaglandin E~
Cultured peripheral blood mononuclear cells from 20 patients with scleroderma were shown to produce high levels of interleukin-la, interleukin-lp, and tumor necrosis factor a. There were positive correlations between the production of these 3 molecules. Purified monocytes from these patients produce
## Abstract ## Objective At sites of inflammation, T cells exert pathologic effects through direct contact with monocyte/macrophages, inducing massive up‐regulation of interleukin‐1 (IL‐1) and tumor necrosis factor α (TNFα). We examined the regulatory effects of IL‐18 on monocyte activation by dir